PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 28.6 CHF -0.52% Market Closed
Market Cap: 943.3m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Cash from Financing Activities
€84.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Cash from Financing Activities
-CHf60.9m
CAGR 3-Years
-52%
CAGR 5-Years
-23%
CAGR 10-Years
-3%
Siegfried Holding AG
SIX:SFZN
Cash from Financing Activities
-CHf75.1m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Cash from Financing Activities
-CHf108m
CAGR 3-Years
23%
CAGR 5-Years
31%
CAGR 10-Years
13%
Tecan Group AG
SIX:TECN
Cash from Financing Activities
-CHf65.3m
CAGR 3-Years
-17%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Cash from Financing Activities
-CHf15.8m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
943.3m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
27.95 CHF
Overvaluation 2%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Cash from Financing Activities?
Cash from Financing Activities
84.5m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Cash from Financing Activities amounts to 84.5m EUR.

Back to Top